Article Details
Retrieved on: 2018-04-27 00:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Baupost Group's</b> Seth Klarman (Trades, Portfolio) disclosed this week he plunged into floundering pharmaceutical company Orexigen Therapeutics Inc. (OREX) on April 13, buying over 7 million shares. Klarman, whose investments range from traditional value plays to distressed debt and liquidations, ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here